Sudair Pharma participated in the Saudi–US Investment Forum, where the company’s CEO, Dr. Yasser Alobaidaa, joined a key discussion panel titled “Healthcare for the Next Generation.”
The session brought together leading experts, decision-makers, and global partners to explore the evolving landscape of healthcare innovation and the strategic role of bilateral cooperation between Saudi Arabia and the United States.
During the panel, Dr. Alobaidaa highlighted the importance of adopting advanced health technologies, fostering innovation across the pharmaceutical and healthcare sectors, and strengthening international collaboration to enhance patient outcomes and sector resilience.
He also emphasized how partnerships and global alliances contribute to accelerating research, supporting technology transfer, and developing sustainable models for future healthcare systems.
Sudair Pharma’s participation reflects its commitment to advancing national healthcare capabilities, promoting knowledge exchange, and contributing to Saudi Arabia’s vision for a more innovative and globally connected healthcare industry.
